NOVO NORDISK A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 903.3 DKK | -1.05% |
|
+2.28% | +29.39% |
| 17/05 | Roche: share price stands out, Deutsche Bank in support | CF |
| 16/05 | Health Care Flat as Momentum Wanes -- Health Care Roundup | DJ |
Presentation Operator MessageOperator (Operator)Good day, and welcome to the Q4 2015 Novo Nord...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
Pharmaceuticals
Calendar
07/08/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
903.3
DKK
Average target price
909.2
DKK
Spread / Average Target
+0.66%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +29.39% | 59TCr | |
| +32.09% | 69TCr | |
| -1.34% | 37TCr | |
| +20.34% | 33TCr | |
| +7.39% | 29TCr | |
| +14.25% | 24TCr | |
| -3.03% | 21TCr | |
| +10.02% | 21TCr | |
| +8.49% | 17TCr | |
| -0.52% | 16TCr |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Transcript : Novo Nordisk A/S, 2015 Earnings Call, Feb 03, 2016
